Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001641172-25-017831

Options or other derivatives

  • Chief Clinical Officer acquired 6,619 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gentry Leesa Chief Clinical Officer 2025-07-01 Grant or award · Stock Option +6,619 6,619 D: show line 1 in the form
Loading xslF345X05/ownership.xml…